New MRI Method for Brain Tumors Detection

Detection of Brain Metastases Using a Novel Gadolinium-Weighted MRI Sequence: A Prospective Comparison

Recruiting Observational Study
Brain Neoplasms
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Region Stockholm · Government
Who this trial is looking for

This trial is looking for people who are 18 or older and are scheduled for a brain MRI with contrast. Participants will receive a standard MRI and a new type of MRI to see if it can find more brain tumors.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years old or older.
  • I am scheduled for a brain MRI with gadolinium contrast.
  • I have known or suspected brain metastases.
  • I can provide informed consent.
  • I can lie still during the MRI.

You may not be able to join if

  • I have contraindications to MRI.
  • I have a known allergy to gadolinium-based contrast agents.
  • I have renal impairment.
  • I am pregnant or breastfeeding.
  • I cannot comply with the study procedures.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study will evaluate a new type of MRI sequence designed to improve the visibility of brain metastases after gadolinium contrast injection. The purpose is to determine whether this novel "gadolinium-weighted" imaging method can detect more or smaller tumors than standard MRI techniques. Participants will undergo a routine brain MRI with contrast, followed by an additional scan using the new me…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * Scheduled for clinical brain MRI with gadolinium contrast * Known or suspected brain metastases * Able to provide informed consent * Able to lie still for the duration of the MRI examination Exclusion Criteria: * Contraindications to MRI * Known aller…
Contacts

No contact information available.